Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Non-cash Items (2019 - 2025)

Cyclerion Therapeutics (CYCN) has 7 years of Non-cash Items data on record, last reported at $242848.0 in Q3 2025.

  • For Q3 2025, Non-cash Items changed N/A year-over-year to $242848.0; the TTM value through Sep 2025 reached $242848.0, changed N/A, while the annual FY2022 figure was $20000.0, N/A changed from the prior year.
  • Non-cash Items reached $242848.0 in Q3 2025 per CYCN's latest filing, down from $251301.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $262967.0 in Q3 2023 and bottomed at $20000.0 in Q4 2022.
  • Average Non-cash Items over 5 years is $184068.3, with a median of $200000.0 recorded in 2021.
  • Peak YoY movement for Non-cash Items: plummeted 50.0% in 2022, then surged 162.97% in 2023.
  • A 5-year view of Non-cash Items shows it stood at $200000.0 in 2021, then crashed by 90.0% to $20000.0 in 2022, then soared by 1214.84% to $262967.0 in 2023, then decreased by 1.68% to $258558.0 in 2024, then fell by 6.08% to $242848.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $242848.0 in Q3 2025, $251301.0 in Q2 2025, and $258558.0 in Q4 2024.